Overview
Congenital myopathy with central nuclei, also known as centronuclear myopathy, is an inherited neuromuscular disorder characterized by muscle weakness and the presence of abnormally centrally located nuclei in muscle fibers on biopsy. This Orphanet entry (172979) is marked as OBSOLETE, meaning it has been retired and its content has been reclassified or merged into other more specific disease entries within the Orphanet classification system. Centronuclear myopathies are now typically categorized under more specific subtypes, including X-linked myotubular myopathy (caused by MTM1 mutations), autosomal dominant centronuclear myopathy (often caused by DNM2 mutations), and autosomal recessive centronuclear myopathy (often caused by BIN1 or RYR1 mutations). These conditions primarily affect skeletal muscles, leading to generalized muscle weakness, hypotonia, and in severe forms, respiratory insufficiency. Facial weakness, ophthalmoplegia (weakness of eye muscles), and ptosis (drooping eyelids) are commonly observed. Severity ranges from severe neonatal presentations with life-threatening respiratory failure to milder forms with later onset. There is currently no cure for centronuclear myopathies; management is supportive and may include respiratory support, physical therapy, and orthopedic interventions. Patients seeking current information should refer to the specific subtypes now classified separately in Orphanet.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Congenital myopathy with central nuclei.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Congenital myopathy with central nuclei at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Congenital myopathy with central nuclei.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Congenital myopathy with central nuclei.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Congenital myopathy with central nuclei.
Start the conversation →Latest news about OBSOLETE: Congenital myopathy with central nuclei
No recent news articles for OBSOLETE: Congenital myopathy with central nuclei.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Congenital myopathy with central nuclei
What is OBSOLETE: Congenital myopathy with central nuclei?
Congenital myopathy with central nuclei, also known as centronuclear myopathy, is an inherited neuromuscular disorder characterized by muscle weakness and the presence of abnormally centrally located nuclei in muscle fibers on biopsy. This Orphanet entry (172979) is marked as OBSOLETE, meaning it has been retired and its content has been reclassified or merged into other more specific disease entries within the Orphanet classification system. Centronuclear myopathies are now typically categorized under more specific subtypes, including X-linked myotubular myopathy (caused by MTM1 mutations), a